Article

Daily OTC Pearl: CalmAid

Author(s):

Saro Arakelians, PharmD

CalmAid helps reduce stress and tension.

OTC/Lifestyle Pearl of the Day: CalmAid

Indication: CalmAid helps reduce stress and tension.

Insights:

  • Contains Silexan
  • Non-drowsy
  • Take 1 soft gel once or twice daily.
  • Take with a full glass of water.
  • Not recommended for individuals younger than aged 12 years.

Source:

CalmAid | Nature's Way (naturesway.com)

Related Videos
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Woman professional nutritionist checking dietary supplements in hand, surrounded by a variety of fruits, nuts, vegetables, and dietary supplements on the table - Image credit: amenic181 | stock.adobe.com
Related Content
Drug Prices, Ozempic, Biktarvy | Image Credit: lucid_dream | stock.adobe.com
January 21st 2025

Ozempic, Biktarvy Among the Drugs Seeing List Price Increases at the Start of 2025

Ashley Gallagher, Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
Cardiovascular Disease, Polypill, Affordability, Adherence | Image Credit: santoelia | stock.adobe.com
January 21st 2025

Polypill Treatment for Cardiovascular Disease Shows Affordability for Majority Black Populations

Ashley Gallagher, Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
woman holding hands near head while suffering from headache in bedroom - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
January 21st 2025

Educate Patients About Nonprescription Products for Self-Treatment of Headaches

Yvette C. Terrie, BSPharm, RPh
https://mjh.sanity.studio/pharmacytimes/structure/article;f92c7f62-819f-4824-89b7-593f5761b127%2Ctemplate%3Darticle
January 21st 2025

Esketamine Receives FDA Approval for Adults With Treatment-Resistant Depression

Alexandra Gerlach, Associate Editor